Brainstorm Cell Therapeutics | BCLI - Net Income


Brainstorm Cell Therapeutics reported $-2.86M in Net Income for its fiscal quarter ending in March of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -5.77M 2.26M Jun/2023
Biogen USD 466.5M 168.3M Sep/2025
Brainstorm Cell Therapeutics USD -2.86M 109K Mar/2025
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -6.98M 360K Sep/2025
CSL USD 497.5M 1.51B Jun/2025
Cytokinetics USD -306.18M 171.81M Sep/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Grifols EUR 148.4M 15.76M Sep/2025
Halozyme Therapeutics USD 175.22M 10.06M Sep/2025
Mesoblast USD -54.21M 6.27M Jun/2025